Brochure
8 May 2025
About Porton
PDF 4.5 MB
Porton Pharma Solutions, a global company with R&D and GMP-compliant manufacturing facilities across the US, EU and China, provides customer-centric innovative and reliable CDMO solutions for Small Molecules, Tides, Biologics and Conjugates (ADCs, AOCs, PDCs, RDCs, etc.), and Advanced Therapy Medicinal Products from pre-clinical to commercial stages
Content provided by our supplier
Porton USA LLC
-
Country/Region:United States
-
On CPHI since:2022
-
Employees:5000+
Company types
Other Content from Porton USA LLC (8)
-
Brochure Biologics and Conjugates CDMO Services
As a subsidiary of Porton Pharma Solutions, a globally recognized CDMO, Porton Biologics and Conjugates CDMO Platform offers comprehensive, one-stop drug development and manufacturing services for biologics and conjugates, including ADCs, AOCs, PDCs, RDCs and more. -
Brochure Tides CDMO Services
With four major R&D platforms including peptides, oligonucleotides, high-performance liquid chromatography, and Tides analysis, the Porton Tides CDMO Services Platform is committed to providing integrated CMC solutions for global customers, covering all types of new drugs from pre-clinical to commercial. -
Brochure Slovenia R&D and Manufacturing Site
It is the first CDMO-type company in the pharmaceutical industry in Slovenia, dedicated to providing comprehensive services to customers, encompassing synthesis route development, process familiarization, analytical method development and validation, and process scale-up. -
Brochure RDC Drugs CDMO Service
Porton has a professional technology platform and an experienced team to provide global clients with CMC solutions for radiopharmaceutical precursors and cold drugs. We are committed to becoming the leading RDC CDMO company in China. -
Brochure PROTAC Technology
A Customer-centric, Innovativeand Reliable CDMO with Global Solutions -
Whitepaper Challenges and Advances in CMC Process Development of BsADCs
Learn how Porton Pharma Solutions Ltd.'s advanced CMC strategies improve selectivity, minimize toxicity, and overcome drug resistance. Understand BsADC design innovations, Discover new conjugation methods, Solve challenges in CMC development, Improve clinical outcomes -
Whitepaper Molecular Modeling and Data Science for De-risking and Cost- saving of Pharmaceutical Development
With advances in computational materials science and process simulation, computational applications are becoming an integral part of the drug development and manufacturing workflow.1,2These methods facilitate easier navigation through the complex multidimensional space of pharmaceutical process development tasks -
Whitepaper Co-processing: Co-Precipitation Technology (CPT) for the Enhancement of Flowability and Bulk Density
Co-processing: Co-Precipitation Technology (CPT) for the Enhancement of Flowability and Bulk Density
Formulating compressed tablets is one of the most widely used oral solid form dosages. However, a vital first step is choosing a suitable manufacturing approach and the right excipients to support the desired therapeutic effect.